A New Approach in Chronic Pain; Acceptance & Commitment Therapy-Exposure & Perspective Taking (ACT-EPT)
ACT-EPT
Study Protocol of a Single Case Methodology Experiement Exploring the Effectiveness and Feasibility of an Exposure-centered ACT Intervention for Chronic Pain Patients: A Pilot Study
1 other identifier
interventional
3
1 country
1
Brief Summary
Background: Chronic pain is a highly prevalent phenomenon with a large impact on the individual's wellbeing. Acceptance and Commitment Therapy (ACT) can be used to help patients relate to chronic pain in a way that helps improve their quality of life. This paper introduces an ACT protocol specific to chronic pain patients: ACT- Exposure and Perspective Taking (ACT-EPT). Aspects specific to this therapy are the focus on exposure as a means to elicit behavioural and emotional change regarding pain experience and it's format as a compact individual therapy. Objectives: Investigators conduct a single case experimental study (ABA design) with a multiple baseline design, aimed at assessing the effectiveness of the experimental ACT-EPT protocol (phase B) compared to usual care (phase A) in individual chronic pain patients. Outcomes include the increase of participation in daily life and health related quality of life, measured with the Short Form-12 (SF-12). Quantitative results will be combined with qualitative results from interviews in a mixed methods design. Participants: Five adults with chronic pain referred to a rehabilitation centre (≥18 years old). Methods: Phases A and B together take 16 weeks for each participant, during which weekly quantitative measurements will be taken. The length of the first phase A will be randomised. The intervention (phase B) consists of weekly ACT-EPT sessions with a maximum of 3 sessions of approximately 90 minutes each. Individual interviews will take place after the last quantitative measurements. These focus on two topics: psychological processes of change and evaluating the intervention.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable chronic-pain
Started Mar 2018
Shorter than P25 for not_applicable chronic-pain
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 10, 2018
CompletedFirst Submitted
Initial submission to the registry
March 19, 2018
CompletedFirst Posted
Study publicly available on registry
March 29, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 10, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
December 10, 2018
CompletedMarch 7, 2019
March 1, 2018
9 months
March 19, 2018
March 6, 2019
Conditions
Outcome Measures
Primary Outcomes (1)
SF-12
The SF-12 measures overall quality of life and includes items that assess participation. The SF-12 is a frequently used measure and has shown to have good internal consistency, reliability, construct validity and responsiveness in patients with chronic (low) back pain (Luo et al., 2003). The measure is a subset of 12 items from the SF-36 including 6 items from the physical summary measure (PCS) and 6 items from the mental summary measure (MCS).
Change between all weekly time-points SF-12 until 16 weeks after randomisation will be calculated
Study Arms (2)
ACT-ETP
EXPERIMENTALCognitive behavioral treatment
Usual care
NO INTERVENTIONno intervention
Interventions
To increase patients' participation by improving their level of coping with chronic pain.
Eligibility Criteria
You may qualify if:
- The patient is diagnosed as having chronic pain, is referred to Winnock Zorg rehabilitation center, location Heerlen or Arnhem, and is registered to receive treatment at Winnock Zorg rehabilitation center;
- The patient has pain of the musculoskeletal system
- The patient has pain for longer than 6 weeks
- The patient is medically stable
- The patient has functional limitations
- The medical history and examination of the patient do not indicate further somatic diagnostics and treatment
- The patient has unwanted psychosocial consequences from the pain, such as in activities of daily life, relationships, work and social role
- Social and psychological factors are complex and play an important role in maintaining the pain, as is assessed by a rehabilitation physician expert
- The patient shows to have insights in his/her functional limitations, as is assessed by a rehabilitation physician expert
- The patient has an active attitude in finding solutions for his/her problem, as is assessed by a rehabilitation physician expert
- The assessment of the patient by a rehabilitation physician expert indicates that the patient is open to receive a cognitive therapy for pain management;
- The patient is at least 18 years old;
You may not qualify if:
- The patient has a history of diagnosed psychotic illness or manic episode;
- The patient has a diagnosed systematic or malignant disease;
- The patient has had a form of Acceptance and Commitment Therapy in the past;
- The patient is using a type of CBT at the moment of the study;
- The patient has a reported substance abuse within 6 months before the trial;
- The patient has a serious medical condition which can be expected to interfere with participation in the study.
- The patient has an inadequate understanding of the written and spoken Dutch language
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Winnock Zorg
Heerlen, 6411 ND, Netherlands
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- The particpant is kept naieve about the fact that the moment of starting the intervention is randomized but coiuld not be blinded for the intervention. The outcome assessor and investigator are blinded for randomization
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 19, 2018
First Posted
March 29, 2018
Study Start
March 10, 2018
Primary Completion
December 10, 2018
Study Completion
December 10, 2018
Last Updated
March 7, 2019
Record last verified: 2018-03
Data Sharing
- IPD Sharing
- Will not share